Therapeutic molecules that bind to LAG3 and PD1 Grant US-11951172-B2 United States of America 09 Apr 2024
Antibodies against signal-regulatory protein alpha and methods of use Grant US-11939393-B2 United States of America 26 Mar 2024
B7-H4 antibodies and methods and use thereof Grant US-11939383-B2 United States of America 26 Mar 2024
Methods of treating cancer with anti-TIM-3 antibodies Grant US-11926665-B2 United States of America 12 Mar 2024
Antibodies and chimeric antigen receptors specific for ROR1 Grant US-11919970-B2 United States of America 05 Mar 2024
Methods of treating allergy using anti-Bet v 1 antibodies Grant US-11897945-B2 United States of America 13 Feb 2024
Methods of inhibiting complement factor H (CFH) comprising administering an antibody that… Grant US-11897946-B2 United States of America 13 Feb 2024
Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof Grant US-11884744-B2 United States of America 30 Jan 2024
ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF Application EP-4026847-A4 European Patent Office 10 Jan 2024
Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for… Grant US-11834506-B2 United States of America 05 Dec 2023
B7-H4 antibodies and methods of use thereof Grant US-11814431-B2 United States of America 14 Nov 2023
Single domain antibodies to programmed cell death (PD-1) Grant US-11814429-B2 United States of America 14 Nov 2023
Glypican 2 as a cancer marker and therapeutic target Grant US-11814440-B2 United States of America 14 Nov 2023
APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF Application EP-3976642-A4 European Patent Office 08 Nov 2023
Methods of treating FGF21-associated disorders Grant US-11802152-B2 United States of America 31 Oct 2023
Composition for prophylaxis or treatment of IL-8 related diseases Grant US-11780912-B2 United States of America 10 Oct 2023
Human antibodies to influenza hemagglutinin Grant US-11780907-B2 United States of America 10 Oct 2023
ZIP12 ANTIBODY Application WO-2023180743-A1 World Intellectual Property Organisation (WIPO) 28 Sep 2023
Human antibodies to Bet v 1 and methods of use thereof Grant US-11767358-B2 United States of America 26 Sep 2023
Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3) Grant US-11753472-B2 United States of America 12 Sep 2023
INTEGRIN ALPHA10 ANTIBODY Application WO-2023166170-A1 World Intellectual Property Organisation (WIPO) 07 Sep 2023
ANTI-PILRA ANTIBODIES, USES THEREOF, AND RELATED METHODS AND REAGENTS Application WO-2023114515-A3 World Intellectual Property Organisation (WIPO) 17 Aug 2023
ANTI-BCMA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND MEDICAL USE THEREOF Application EP-4006055-A4 European Patent Office 19 Jul 2023
Method of detecting the presence of complement C5 Grant US-11597760-B2 United States of America 07 Mar 2023
NEUTRALIZING ANTIBODIES DIRECTED TO SARS-COV-2 SPIKE PROTEIN Application WO-2023025813-A1 World Intellectual Property Organisation (WIPO) 02 Mar 2023
Single domain antibodies to programmed cell death protein 1 (PD-1) Grant US-11591398-B2 United States of America 28 Feb 2023
COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS Application US-20230039927-A1 United States of America 09 Feb 2023
ANTI-CLAUDIN 18.2 ANTIBODY AND APPLICATION THEREOF Application EP-3950716-A4 European Patent Office 09 Nov 2022
Polynucleotides encoding anti-C5 antibodies Grant US-11492392-B2 United States of America 08 Nov 2022
Methods of treating C5-associated diseases comprising administering anti-C5 antibodies Grant US-11479602-B2 United States of America 25 Oct 2022
Anti-HSV GB monoclonal antibody or antigen-binding fragment thereof Grant US-11472867-B2 United States of America 18 Oct 2022
Anti-Sortilin antibodies and methods of use thereof Grant US-11396546-B2 United States of America 26 Jul 2022
Anti-C5 antibody combinations and uses thereof Grant US-11365265-B2 United States of America 21 Jun 2022
Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3) Grant US-11352427-B2 United States of America 07 Jun 2022
TRAILshort ANTIBODY AND METHODS OF USE Application US-20220127370-A1 United States of America 28 Apr 2022
Single-domain antibodies to programmed cell death 1 protein (PD-1), encoding nucleic… Grant US-11312771-B2 United States of America 26 Apr 2022
Methods of treating FGF21-associated disorders Grant US-11236159-B2 United States of America 01 Feb 2022
T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide… Grant US-11168150-B2 United States of America 09 Nov 2021
ANTIBODY-DRUG CONJUGATES TARGETING UPARAP Application EP-3895736-A1 European Patent Office 20 Oct 2021
ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS Application US-20210198374-A1 United States of America 01 Jul 2021
ANTIBODIES HAVING SPECIFICITY TO HER4 AND USES THEREOF Application WO-2021116119-A1 World Intellectual Property Organisation (WIPO) 17 Jun 2021
ANTI-CD27 ANTIBODIES AND USES THEREOF Application US-20210155703-A1 United States of America 27 May 2021
ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE Grant EP-3071597-B1 European Patent Office 29 Jul 2020
STABILIZED PRE-FUSION RSV F PROTEINS Application WO-2020099383-A1 World Intellectual Property Organisation (WIPO) 22 May 2020
Anti-alpha-synuclein antibodies and methods of use Grant US-10647761-B2 United States of America 12 May 2020
Anti-factor XI monoclonal antibodies and methods of use thereof Grant US-10577428-B2 United States of America 03 Mar 2020
ANTI-ALPHA-SYNUCLEIN ANTIBODIES Application WO-2019115674-A1 World Intellectual Property Organisation (WIPO) 20 Jun 2019
Antibody neutralizers of human granulocyte macrophage colony stimulating factor Grant US-10138297-B2 United States of America 27 Nov 2018
Methods and compositions for treatment of Pompe disease Grant US-10017581-B2 United States of America 10 Jul 2018
Antigen binding proteins that bind CCR2 Application US-9951138-B2 United States of America 24 Apr 2018
ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE Application EP-3259287-A1 European Patent Office 27 Dec 2017
Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated… Grant EP-2407486-B1 European Patent Office 22 Nov 2017
ANTI HUMAN IP-10 ANTIBODIES AND THEIR USES Application WO-2017095875-A1 World Intellectual Property Organisation (WIPO) 08 Jun 2017
Anti-factor XI monoclonal antibodies and methods of use thereof Grant US-9636399-B2 United States of America 02 May 2017
HUMANIZED ANTIBODIES AGAINST CD269 (BCMA) Application EP-3137500-A1 European Patent Office 08 Mar 2017
ANTIBODIES AGAINST CCR9 AND APPLICATIONS THEREOF Application EP-3074421-A1 European Patent Office 05 Oct 2016
BINDING PROTEINS SPECIFIC FOR LOX1 AND USES THEREOF Application WO-2016050889-A1 World Intellectual Property Organisation (WIPO) 07 Apr 2016
CD20-specific antibodies and methods of employing same Application EP-2960251-A1 European Patent Office 30 Dec 2015
ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF Application US-20150322163-A1 United States of America 12 Nov 2015
ANTI-FXI ANTIBODIES AND METHODS OF USE Application US-20150093395-A1 United States of America 02 Apr 2015